Contact Us

Yes. KCNC1 rescue experiments require attention to channel architecture: • Construct design: use a codon-modified KCNC1 sequence with a small intracellular C- or N-terminal tag (FLAG, HA). Kv3.1 has six transmembrane domains (S1-S6) with voltage sensor (S4) and pore loop (between S5 and S6) — preserve membrane topology. • Non-conducting rescue: W432R or pore-loop mutations abolish K+ conduction and serve as the standard specificity control. • EPM7 mutation rescue: R320H gain-of-function variant enables disease genotype-function studies of progressive myoclonus epilepsy. • Functional readout: rescue should restore voltage-activated K+ currents measured by whole-cell patch clamp in heterologous expression contexts. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying KCNC1 (Kv3.1)'s role as a high-threshold fast-activating/deactivating voltage-gated potassium channel or modeling progressive myoclonus epilepsy type 7 (EPM7). The Knockout line is the standard tool for asking whether KCNC1 is required for predicted channel functions — Kv3.1 is a member of the Kv3 family (Kv3.1, Kv3.2, Kv3.3, Kv3.4) of voltage-gated K+ channels with distinctive high-threshold activation enabling fast-spiking neuron firing (parvalbumin-positive interneurons, fast-spiking interneurons). Overexpression is useful for studying KCNC1 in heterologous expression contexts. Important consideration: KCNC1 is principally functional in fast-spiking neurons — HAP1 is not the physiological context for canonical Kv3.1 function. The EDITGENE Knockout in HAP1 is most useful for biochemistry, channel surface expression studies, and as a clean genetic background. KCNC1 R320H gain-of-function mutation causes EPM7 — disease variant rescue enables genotype-function studies. Rescue with wild-type or non-conducting (W432R pore mutation) KCNC1 is the standard specificity control.

Yes. Trem2 rescue experiments are particularly well-characterized given Trem2's prominence in neurodegeneration research: • Construct design: use a codon-modified Trem2 sequence with a C-terminal tag (FLAG, HA). Trem2 is a single-pass transmembrane protein — N-terminal tags after the signal peptide cleavage site, or C-terminal cytoplasmic tags, are both viable. • Disease variant rescue: rescue with Alzheimer's disease-associated TREM2 variants (R47H, R62H, Y38C) is a standard approach for studying genotype-function relationships in microglial biology. • DAP12/TYROBP coupling: Trem2 signals through DAP12 — rescue interpretation should consider that some disease variants affect Trem2-DAP12 association rather than expression. • Functional readout: rescue should restore phagocytic capacity, DAM transcriptional program activation, and inflammatory response modulation. BV-2 transduces efficiently with lentivirus and supports stable rescue line generation; standard mammalian expression systems work well in this murine microglial background.

The choice depends on whether you are studying Trem2's role in microglial function, neurodegeneration risk, or its emerging functions in tumor-associated macrophages. The Knockout line is the standard tool for both — TREM2 variants (R47H, R62H) increase Alzheimer's disease risk through loss-of-function effects, and Trem2 KO recapitulates many aspects of microglial dysfunction observed in disease models. Overexpression is useful for studying gain-of-function effects or for testing whether elevated Trem2 enhances phagocytic capacity. For neurodegeneration research, the EDITGENE Trem2 Knockout in BV-2 is highly relevant — BV-2 is the standard murine microglial line, and Trem2 KO phenotypes (impaired phagocytosis, altered DAM transcriptional programs, reduced lipid metabolism gene expression) are well-characterized in microglial models. Rescue with wild-type or disease-associated mutant (R47H, R62H) Trem2 is particularly informative for genotype-function studies.

Yes. NLRP3 rescue experiments are well-established for microglial neuroinflammation research: • Construct design: use a codon-modified Nlrp3 sequence with a small C-terminal tag (FLAG, HA). Mouse Nlrp3 has N-terminal PYD, NACHT, and C-terminal LRR — preserve all elements. • CAPS mutation rescue: patient-derived activating mutations (R262W, D305N, Y570C, V200M corresponding human numbering) introduced for genotype-function studies of cryopyrin-associated periodic syndromes. • Activation-deficient rescue: Walker A motif mutations in NACHT abolish NTP binding and inflammasome activation. • Functional readout: rescue should restore LPS-priming + nigericin-induced ASC speck formation, caspase-1 cleavage, IL-1β/IL-18 release, and gasdermin-D-mediated pyroptosis. BV-2-specific considerations: • BV-2 is an immortalized murine microglial cell line (v-raf/v-myc transformed C57BL/6 microglia) — the most widely used continuous microglial cell line for in vitro neuroimmunology research. • Lentiviral transduction is supported with moderate efficiency; characterize basal microglial activation state (M1/M2 markers) before phenotypic assays. • BV-2 retains key microglial markers (CD11b, Iba1, CD68) and TLR/inflammasome responses, but immortalization may alter some primary microglial features — confirm relevant phenotypes in independent assays.

The choice depends on whether you are studying NLRP3 inflammasome activation in microglia or modeling NLRP3-mediated neuroinflammation in Alzheimer's disease, Parkinson's disease, and other neurodegenerative contexts. The Knockout line is the standard tool for asking whether NLRP3 is required for microglial inflammasome assembly — NLRP3 in microglia responds to amyloid-β fibrils, α-synuclein aggregates, tau, and other DAMPs implicated in neurodegeneration. Overexpression is useful for studying CAPS-associated gain-of-function NLRP3 mutations. For neuroinflammation research, the EDITGENE Nlrp3 Knockout in BV-2 is uniquely valuable — BV-2 is the most widely used immortalized murine microglial cell line, providing a tractable system for studying microglial NLRP3 biology relevant to neurodegenerative disease. Rescue with wild-type or CAPS-associated activating mutant (e.g., R262W, D305N, Y570C) NLRP3 enables comprehensive disease genotype-function studies. The knockout is a critical specificity control for MCC950/CRID3 (and clinical candidates inzomelid, somalix) and dapansutrile (OLT1177, in clinical trials for heart failure and gout) in neurological drug development.

Yes. Hk2 rescue experiments are well-established for metabolic research: • Construct design: use a codon-modified Hk2 sequence with a small C-terminal tag (FLAG, HA). Hk2 has tandem N- and C-terminal hexokinase domains and N-terminal mitochondrial outer membrane association sequence — preserve all elements. • Catalytically-dead rescue: substrate-binding pocket mutations abolish hexokinase activity and serve as the standard specificity control. • Mitochondrial-binding-deficient rescue: N-terminal MOM-association motif mutations (e.g., 'NB' deletion) generate cytosolic Hk2 for studying VDAC-association versus catalytic functions. • Functional readout: rescue should restore glycolytic flux measured by lactate production and Seahorse ECAR. RAW 264.7-specific considerations: • RAW 264.7 is a chemically induced (Abelson murine leukemia virus-transformed) BALB/c-derived macrophage cell line — the most widely used continuous murine macrophage model for innate immunity, inflammation, and macrophage metabolism research. • Lentiviral transduction is supported with moderate efficiency. • Macrophage polarization (M1/M2) responses are preserved; characterize basal activation state before phenotypic assays.

The choice depends on whether you are studying Hk2 (hexokinase 2)'s role as a key glycolytic enzyme in macrophage metabolic reprogramming (Warburg-like metabolism) or modeling its functions in inflammatory macrophage activation. The Knockout line is the standard tool for asking whether Hk2 is required for these processes — Hk2 is the rate-limiting first step of glycolysis (glucose → glucose-6-phosphate), and is uniquely upregulated in activated macrophages, cancer cells, and other glycolysis-dependent cells; Hk2 also has non-canonical roles in mitochondrial outer membrane association via VDAC and apoptosis regulation. Overexpression is useful for studying Hk2 gain-of-function effects. For macrophage immunology research, the EDITGENE Hk2 Knockout in RAW 264.7 is highly informative — RAW 264.7 is the gold-standard murine macrophage cell line, and Hk2 upregulation is a hallmark of LPS-induced M1 macrophage metabolic reprogramming. Other hexokinase (HK1, HK3) expression analysis aids interpretation given partial functional overlap. Rescue with wild-type or catalytically-dead Hk2 enables structure-function studies. The knockout is valuable for studying macrophage immunometabolism, Hk2-VDAC mitochondrial association, and emerging Hk2-targeted therapeutics (2-deoxyglucose, lonidamine, 3-bromopyruvate).

Yes. ZIP6 rescue experiments require attention to ZIP10 heterodimer biology: • Construct design: use a codon-modified SLC39A6 sequence with a small C-terminal tag (FLAG, HA). ZIP6 has 8 transmembrane domains — N-terminal tags after the signal peptide are tolerated. • ZIP10 partnership: ZIP6 and ZIP10 form heterodimers; rescue interpretation should consider ZIP10 expression in HEK293. • Transport-deficient rescue: histidine-rich loop mutations or transmembrane zinc-binding residue mutations enable structure-function studies. • Functional readout: rescue should restore zinc uptake activity (FluoZin-3 imaging) and downstream EMT-related phenotypes where relevant. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SLC39A6 (ZIP6/LIV-1)'s role in zinc uptake or its emerging functions in epithelial-mesenchymal transition (EMT) and cancer biology. The Knockout line is appropriate for asking whether ZIP6 is required for cellular zinc influx — particularly relevant in breast cancer contexts where ZIP6 is estrogen-regulated and associated with tumor progression. Overexpression is useful for studying ZIP6 in EMT and cancer phenotypes. For ZIP6 research, the EDITGENE Knockout in HEK293 is a mechanistic platform for zinc transport biology and EMT mechanism studies. ZIP family compensation should be assessed (ZIP10 is the closest paralog and forms heterodimers with ZIP6). Rescue with wild-type or transport-deficient ZIP6 enables structure-function studies. ZIP6 is also a target for ADC development (ladiratuzumab vedotin) — the knockout serves as a specificity control.

Yes. Nsun2 rescue experiments are well-established for RNA modification research: • Construct design: use a codon-modified Nsun2 sequence with a small C-terminal tag (FLAG, HA). Nsun2 has N-terminal SAM-binding methyltransferase domain and C-terminal regulatory region — preserve both. • Catalytically-dead rescue: C271A/C321A double mutation in the catalytic cysteines abolishes methyltransferase activity and is the standard specificity control. • Functional readout: rescue should restore tRNA and mRNA m5C levels measured by bisulfite sequencing or mass spectrometry. TC1 mESCs require feeder cell co-culture or feeder-free conditions with LIF — lentiviral transduction of mESCs is supported but requires optimization; transgene silencing during differentiation should be monitored using silencing-resistant promoters. Confirm pluripotency markers (Oct4, Nanog, SSEA-1) and karyotype stability after rescue line generation.

The choice depends on whether you are studying Nsun2 (NOL1/NSUN2)'s role as the principal m5C tRNA methyltransferase or its emerging functions in mRNA m5C methylation and pluripotency. The Knockout line is the standard tool for asking whether Nsun2 is required for m5C deposition — Nsun2 generates 5-methylcytosine (m5C) modifications on tRNAs (notably tRNA-Leu C34 region), mRNAs, and ncRNAs, with established roles in stem cell biology and Dubowitz-like syndrome (NSUN2 mutations cause autosomal recessive intellectual disability). Overexpression is useful for studying Nsun2 in heterologous expression contexts. For RNA modification and stem cell research, the EDITGENE Nsun2 Knockout in TC1 mouse ESC is highly valuable — TC1 is a 129S6/SvEvTac-derived mouse embryonic stem cell line, providing a pluripotent stem cell background to study m5C's role in self-renewal and differentiation. Rescue with wild-type or catalytically-dead (C271A/C321A double mutation in the catalytic cysteines) Nsun2 enables structure-function studies. The mouse ESC background uniquely enables differentiation studies to characterize m5C's role in lineage specification. The model is valuable for m5C epitranscriptomics research.

The kit can detect Mycoplasma in common cell culture reagents, such as media and serum, without the need for sample preparation. Simply proceed directly to PCR reaction and gel loading. However, the kit cannot detect Mycoplasma in organic solvents like DMSO or ethanol.

Use a freshly opened negative control for retesting. Ensure to change pipette tips during sample loading and prioritize loading the negative control first to avoid cross-contamination between samples.

PCR detection of Mycoplasma is highly sensitive, so avoid cross-contamination between samples. Ensure sterile conditions when handling each sample individually. After sample processing and PCR reaction, allow samples to cool before proceeding to the next step to avoid aerosol contamination.